Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Reversal of Remimazolam Sedation With Flumazenil on Cognitive Function in Patients Undergoing Hip Arthroplasty Under Spinal Anesthesia

NCT07277881 is registered in ClinicalTrials.gov with Medical University of Gdansk as lead sponsor.

NCT NCT07277881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07277881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Reversal of Remimazolam Sedation With Flumazenil on Cognitive Function in Patients Undergoing Hip Arthroplasty Under Spinal Anesthesia
Lead sponsor
Medical University of Gdansk
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
October 31, 2028
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hip arthroplasty, total, postoperative delirium, remimazolam, sedation